KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Assets: 2020-2025

Historic Return on Assets for Royalty Pharma (RPRX) over the last 5 years, with Sep 2025 value amounting to 0.07%.

  • Royalty Pharma's Return on Assets fell 3.00% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of 0.08% for FY2024, which is 3.00% down from last year.
  • Latest data reveals that Royalty Pharma reported Return on Assets of 0.07% as of Q3 2025, which was down 25.37% from 0.09% recorded in Q2 2025.
  • Over the past 5 years, Royalty Pharma's Return on Assets peaked at 0.12% during Q2 2021, and registered a low of 0.01% during Q4 2022.
  • In the last 3 years, Royalty Pharma's Return on Assets had a median value of 0.07% in 2024 and averaged 0.07%.
  • Per our database at Business Quant, Royalty Pharma's Return on Assets fell by 8bps in 2021 and then rose by 9bps in 2023.
  • Over the past 5 years, Royalty Pharma's Return on Assets (Quarterly) stood at 0.07% in 2021, then dropped by 6bps to 0.01% in 2022, then climbed by 9bps to 0.11% in 2023, then decreased by 3bps to 0.07% in 2024, then decreased by 3bps to 0.07% in 2025.
  • Its Return on Assets was 0.07% in Q3 2025, compared to 0.09% in Q2 2025 and 0.10% in Q1 2025.